Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2017

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2017
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.06 +0.69 (5.16%)
Previous Close $13.37    52 Week High $34.49 
Open $13.22    52 Week Low $20.39 
Day High $14.12    P/E N/A 
Day Low $12.92    EPS $-3.18 
Volume 401,621